- Landmark five-year $40-million global research study aims to identify biomarkers of Parkinson's disease progression, critical tools for drug development -
NEW YORK, Sept. 28 /PRNewswire-USNewswire/ -- The Michael J. Fox Foundation has launched the Parkinson's Progression Markers Initiative (PPMI)